Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | COPA | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | SCAMP3 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | RFT1 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
mRNA | ETF1 | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-07 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-05 |
mRNA | LMNA | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |